Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-117-5 | CAS number: 3007-53-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The bioavailability of the substance can be confirmed through different routes. Possible uptake routes are dermal, oral and inhalative. Further it can be assume that the substance is wide distributed, metabolised via phase 1 and 2 enzymes (via N-demethylase or/and P450) and extreted via urine. Accumulation seems unlikely.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
There were no studies available in which the toxicokinetic properties (distribution, metabolism, elimination) of the N,N-dimethyldodecanamide were investigated.
N,N-dimethyldodecanamide having a molecular weight of ~227,38 g/mol is a liquid with a water solubility of 0.028 g/L. It has a very low volatility of < 0.17 Pa (20°C) and has a strong lipophilic character (log Pow = 5.2). The structure shows ionic elements.
The expected toxicokinetic behaviour is derived from the physicochemical properties, the results from the available toxicological studies and the available literature following the information given in guidance document 7c.
Please note that the real behaviour may be different but can only be determined with ADME studies, which are not justified based on the very low toxicity of the substance. Additionally a few information are derived from acute or repeated dose studies of a N,N-dimethyloctan-1-amide / N,N-dimethyldecan-1-amide – mixture.
Oral and GI absorption:
Based on the phys. Chem. data, it can be expected that substance is ionisable and therefore do not readily diffuse across biological membranes. Due to the high hydrophilic properties passive diffusion may be less relevant in absorption, nevertheless it can be expected, that absorption happens via micellular solubilisation but that due to the highly lipophilic properties substance has a limited ability to dissolve into GI fluids. Based on this it can be expected that the substance can be absorbed and that the major fraction is parent compound or parent compound metabolites. As acute toxicity studies for close homologues (with shorter carbon chain length) show low toxicity (decreasing in toxicity with increasing carbon chain length) but indicate some effects at 5000mg/kg bw. (see BASF 1997 for CAS 14433-76-2) the oral bioavailability of the test material is indicated. Further, a 90 day feeding study (Bayer 2000) with beagle conducted with a close homologue indicate also the systemic availability of the substance.
Inhalative absorption:
The substance itself has a low vapour pressure, therefore inhalation of vapours is expected not to reach sufficient amount for any effects. Nevertheless if sprays are generated and inhaled possible higher amounts may reach the lower respiratory region. Due to the high hydrophilic properties and the low water solubility the substance may be taken up be micellular solubilisation also partly a direct absorption may be possible. But results from a close homologue show no toxicity (despite irriation) if the highest attainable dose is inhaled (see acute inhalation study C8/C10 mixture (Bayer 1991, LC50= 3551 mg/m3) and an repeated dose sighting inhalation study where 111.2mg/m3 C8/C10 aerosol were tolerated (Bayer 1992; 5x6h)).
In summary mist may be reach the lower respiratory region an may also be absorbed but expected toxic are low despite irritation.
Dermal absorption:Due to the physicochemical information of the substance absorption via skin is anticipated to be low due to its low solubility. Further N,N-dimethyldodecanamide has a limited rate of penetration due to its lipophilic character, but small uptake into the epidermis can not fully be excluded. Nevertheless due to lipophilic character the substance may readily penetrate the lipid rich stratum corneum but in summary is not well absorbed systemically. An in-vitro study (BASF, 2014) revealed a skin irritation potential of N,N-dimethyldodecanamide and due to this damage, the substance can possible enhance skin penetration. In addition, literature indicated that a maximum skin penetration enhancing effect is measured for C8 and C10 dimethylalkylamides.
Distribution:The physicochemical information points due to the small molecule size to a wide distribution of the substance but less diffusion through aqueous pores and channels because of its lipophilic character. Further it can be assumed that the substance is likely distributed into cells, especially in fatty tissue (log P>0). Im summary a wide distribution can be assumed.
Accumulative potential:Due to the water solubility and distribution an accumulation in general is unlikely. Nevertheless, if accumulation happens the main site of accumulation is assumed to be the adipose tissue. Lipophilic substances will tend to concentrate in adipose tissue and may accumulate, if the interval between exposure is less than 4 times of the whole body half-life of the substance. Furthermore highly lipophilic substances can readily penetrate the lipid rich stratum corneum but are not well absorbed systemically. Although the may persist in the stratum corneum, they will eventually be cleared as the stratum corneum is sloughed off. No accumulation in bone or in lung is predicted.
Metabolism:
No detail information is available concerning the metabolism. Based on the general structure of the molecule itcan be assumed that metabolisation (via N-demethylase or/and P450) appears, degrading the substance, further the metabolites may be conjugated via phase II enzymes creating molecules with molecular masses preferred for kidney elimination.
Reactivity:
Available studies on genotoxicity with N,N-dimethyloctan-1-amide / N,N-dimethyldecan-1-amide were negative, i. e. there is no indication of a reactivity against DNA of homologe dimethylamides in genotoxicity assays are observed.
Excretion:
Based on the molecular weight and water solubility it can be assumed that the substance or its metabolites are mainly excreted via urine. Nevertheless due to the lipophilic character of the parent substance these molecular maybe also found in the bile. Metabolites will have more hydrophilic properties and therefore be excreted via urine. If dermal application appears also a portion of the substance could be eliminated via exfoliation.
Due to a assumed metabolism the main route of excretion is expected to be via kidney but small portions maybe also found in the bile.
In summary:The bioavailability of the substance can be confirmed through different routes. Possible uptake routes are dermal, oral and inhalative. Further it can be assume that the substance is wide distributed, metabolised via phase 1 and 2 enzymes (via N-demethylase or/and P450) and extreted via urine. Accumulation seems unlikely.
In a worst case assumption full absorption via all routes are assumed as the substance penetrates thru skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.